Characteristics of Laboratory Markers in Alcohol-Related Organ Damage

References

• Salaspuro M. Conventional and coming laboratory markers of alcoholism and heavy drinking. Alcohol Clin Exp Res 1986; 10: 5S–12S
   Google Scholar
• Lumeng L. New diagnostic markers of alcohol abuse. Hepatology 1986; 6: 742–745
   PubMedGoogle Scholar
• Salaspuro M. Use of enzymes for the diagnosis of alcohol-related organ damage. Enzyme 1987; 37: 87–107
   PubMedGoogle Scholar
• Staun-Olsen P, Thomsen A C. Serum ethanol estimations in the control of abstinence in patients with liver disease. Scand J Gastroenterol 1979; 14: 785–789
   PubMed Web of Science ®Google Scholar
• Sobell M, Sobell L, Van Der Spek R. Relationships among clinical judgment, self-report, and breath analysis measures of intoxication in alcoholics. J Consult Clin Psychol 1979; 47: 204–206
   PubMed Web of Science ®Google Scholar
• Orrego H, Blake J E, Israel Y. Relationship between gamma-glutamyl-transpeptidase and mean urinary alcohol levels in alcoholics while drinking and after alcohol withdrawal. Alcohol Clin Exp Res 1985; 9: 10–13
   PubMed Web of Science ®Google Scholar
• Senior J R, Sloan B P. Emergency measurement of stat, timed, serum ethanol levels for medical management. Alcohol Clin Exp Res 1981; 5: 6–11
   PubMed Web of Science ®Google Scholar
• Criteria Committee, National Council on Alcoholism. Criteria for the diagnosis of alcoholism. Ann Intern Med 1972; 77: 249–258
   PubMed Web of Science ®Google Scholar
• Wu A, Chanarin I, Levi A J. Macrocytosis of chronic alcoholism. Lancet 1974; 1: 829–830
   PubMed Web of Science ®Google Scholar
• Unger K W, Johnson D, Jr. Red blood cell mean corpuscular volume: a potential indicator of alcohol usage in a working population. Med Sci 1974; 267: 281–289
   Google Scholar
• Chalmers D M, Levi A J, Chanarin I, North W RS, Meade T W. Mean cell volume in a working population: alcohol and oral contraception. Br J Haematol 1979; 43: 631–636
   PubMedGoogle Scholar
• Morgan M Y, Camilo M E, Luck W, Sherlock S, Hoffbrand A V. Macrocytosis in alcohol-related liver disease: its value for screening. Clin Lab Haematol 1981; 3: 35–44
   PubMedGoogle Scholar
• Chick J, Kreitman N, Plant M. Mean cell volume and gamma-glutamyltranspeptidase as markers of drinking in working men. Lancet 1981; 1: 1249–1251
   PubMed Web of Science ®Google Scholar
• Carnery M WP, Sheffield B. Serum folate and B12 and haematological status of in-patient alcoholics. Br J Addict 1978; 73: 3–7
   Google Scholar
• Whitfield J B. Alcohol-related biochemical changes in heavy drinkers. Aust NZ J Med 1981; 11: 132–139
   PubMedGoogle Scholar
• Rollason J G, Pincherle G, Robinson D. Serum gamma glutamyl-transpeptidase in relation to alcohol consumption. Clin Chim Acta 1972; 39: 75–80
   PubMed Web of Science ®Google Scholar
• Seymour C A, Peters T J. Changes in hepatic enzymes and organelles in alcoholic liver disease. Clin Sci mol Med 1978; 55: 383–389
   PubMedGoogle Scholar
• Ishii H, Ebihara Y, Okuno F, et al. Gamma-glutamyltranspeptidase activity in liver of alcoholics and its histochemical localization. Alcohol Clin Exp Res 1986; 10: 81–85
   PubMedGoogle Scholar
• Teschke R. Gamma-glutamyltransferase and other markers for alcoholism. Alcohol related diseases in gastroenterology, H Seitz, B Kommerell. Springer-Verlag, Berlin 1985; 48–64
   Google Scholar
• Devgun M S, Dunbar J A, Hagart J, Martin B T, Ogston S A. Effects of acute and varying amounts of alcohol consumption on alkaline phosphatase, aspartate transaminase, and gamma-glutamyl-transferase. Alcohol Clin Exp Res 1985; 9: 235–237
   PubMed Web of Science ®Google Scholar
• Nishimura M, Hasumura Y, Takeuchi J. Effect of an intravenous infusion of ethanol on serum enzymes and lipids in patients with alcoholic liver disease. Gastroenterology 1980; 78: 691–695
   PubMedGoogle Scholar
• Rosalki S B, Rau D. Serum gamma-glutamyl tran-peptidase activity in alcoholism. Clin Chim Acta 1972; 39: 41–47
   PubMed Web of Science ®Google Scholar
• Gluud C, Andersen I, Dietrichson O, Gluud B, Jacobsen A, Juhl E. Gamma-glutamyl transferase, aspartate aminotransferase and alkaline phosphatase as markers of alcohol consumption in outpatient alcoholics. Eur J Clin Invest 1981; 11: 171–176
   PubMed Web of Science ®Google Scholar
• Kristenson H, Trell E, Fex G, Hood B. Serum gamma-glutamyltransferase: statistical distribution in a middle-aged male population and evaluation of alcohol habits in individuals with elevated levels. Prev Med 1980; 9: 108–119
   PubMed Web of Science ®Google Scholar
• Penn R, Worthington U, Clarke C A, Whitfield A GW. Gamma-glutamyl-transpeptidase and alcohol intake. Lancet 1981; 1: 894
   Google Scholar
• Whitehead T P, Pandov H, Clark D M. Gamma-glutamyltranspeptidase and alcohol problems. Lancet 1981; 1: 663
   PubMedGoogle Scholar
• Penn R, Worthington D J. Is serum gamma-glutamyltransferase a misleading test?. Br Med J 1983; 286: 531–535
   PubMed Web of Science ®Google Scholar
• Poikolainen K, Kärkkäinen P, Pikkarainen J. Correlations between biological markers and alcohol intake as measured by diary and questionnaire in man. J Stud Alcohol 1985; 46: 383–387
   PubMed Web of Science ®Google Scholar
• Morgan M Y, Colman J C, Sherlock S. The use of a combination of peripheral markers for diagnosing alcoholism and monitoring for continued abuse. Br J Alcohol 1981; 16: 167–177
   Google Scholar
• Wadstein J, Skude G. Changes in amylase, hepatic enzymes and bilirubin in serum upon initiation of alcohol abstinence. Acta Med Scand 1979; 205: 313–316
   PubMedGoogle Scholar
• Wadstein J, Skude G. Serum ethanol, hepatic enzymes and length of debauch in chronic alcoholics. Acta Med Scand 1979; 205: 317–318
   PubMedGoogle Scholar
• Whitfield J B, Pounder R E, Neale G, Moss D W. Serum gamma-glutamyltranspeptidase activity in liver disease. Gut 1972; 13: 702–708
   PubMed Web of Science ®Google Scholar
• Lum G, Gambino S R. Serum gamma-glutamyltranspeptidase activity as an indicator of disease of liver, pancreas and bone. Clin Chem 1972; 18: 358–362
   PubMed Web of Science ®Google Scholar
• Ellis G, Worthy E, Goldberg D M. Lack of value of serum gamma-glutamyltransferase in the diagnosis of hepatobiliary disease. Clin Biochem 1979; 12: 142–145
   PubMed Web of Science ®Google Scholar
• Wu A, Slavin G, Levi A J. Elevated serum gamma-glutamyltransferase (transpeptidase) and histological liver damage in alcoholism. Am J Gastroenterol 1976; 65: 318–323
   PubMed Web of Science ®Google Scholar
• Ryback R S, Eckhardt M J, Felsher B, Rawlings R R. Biochemical and hematologic correlates of alcoholism and liver disease. JAMA 1982; 248: 2261–2265
   PubMed Web of Science ®Google Scholar
• Zein M, Discombe G. Serum gamma-glutamyltranspeptidase as a diagnostic aid. Lancet 1970; 2: 748–750
   PubMed Web of Science ®Google Scholar
• Lehmann D, Prentice M, Rosalki S B. Plasma gamma-glutamyltranspeptidase activity following renal transplantation. Ann Clin Biochem 1970; 7: 148–151
   Google Scholar
• Agostini A, Ideo G, Stabilini R. Serum gamma-glutamyltranspeptidase activity in myocardial infarction. Br Heart J 1965; 27: 688–690
   PubMedGoogle Scholar
• Hedworth-Whitty R B, Whitfield J, Richardson R W. Serum gamma-glutamyltranspeptidase activity in myocardial ischaemia. Br Heart J 1967; 29: 432–438
   PubMedGoogle Scholar
• Konttinen A, Härtel G, Louhija A. Multiple serum enzyme analyzes in chronic alcoholics. Acta Med Scand 1970; 188: 257–264
   PubMed Web of Science ®Google Scholar
• Rosalki S B, Tarlow D, Rau D. Plasma gamma-glutamyltranspeptidase elevation in patients receiving enzyme-inducing drugs. Lancet 1971; 2: 376–377
   PubMed Web of Science ®Google Scholar
• Whitfield J B, Moss D W, Neale G, Orme M, Breckeridge A. Changes in plasma-gamma-glutamyltranspeptidase activity associated with alterations in drug metabolism in man. Br Med J, 3: 274, 316–318
   Google Scholar
• Morland J, Huseby N E, Sjdblom M, Stromme J H. Does chronic alcohol consumption really induce hepatic microsomal gamma-glutamyltransferase activity?. Biochem Biophys Res Commun 1977; 77: 1060–1066
   PubMedGoogle Scholar
• Mezey E. Alcohol consumption and gamma-glutamyltransferase activity. Gastroenterology 1978; 74: 632–633
   Google Scholar
• Schiele F, Guilman A-M, Detienne H, Siest G. Gamma-glutamyltransferase activity in plasma: statistical distributions, individual variations, and reference intervals. Clin Chem 1977; 23: 1023–1028
   PubMed Web of Science ®Google Scholar
• Mendenhall C L, The VA Cooperative Study Group on Alcoholic Hepatitis. Alcoholic hepatitis. Clin Gastroenterol 1981; 10: 417–441
   PubMedGoogle Scholar
• McIntyre N, Heathcote J. The laboratory in the diagnosis and management of viral hepatitis. Clin Gastroenterol 1974; 3: 317–336
   PubMedGoogle Scholar
• Matloff D S, Selinger M J, Kaplan M M. Hepatic transaminase activity in alcohol liver disease. Gastroenterology 1980; 78: 1389–1392
   PubMed Web of Science ®Google Scholar
• Ludwig S, Kaplowitz N. Effect of pyridoxine deficiency on serum and liver transaminases in experimental liver injury in the rat. Gastroenterology 1980; 79: 545–549
   PubMedGoogle Scholar
• Diehl A M, Potter J, Boitnott J, van Duyn M A, Herlong H F, Mezey E. Relationship between pyri-doxal 5′-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984; 86: 632–636
   PubMed Web of Science ®Google Scholar
• Chana Yeung M, Ferreira P, Frohlich J, Shulzer M, Tan F. The effects of age, smoking and alcohol on routine laboratory tests. Am J Clin Pathol 1981; 75: 320–326
   PubMedGoogle Scholar
• Skude G, Wadstein J. Amylase, hepatic enzymes and bilirubin in serum of chronic alcoholics. Acta Med Scand 1977; 201: 53–58
   PubMedGoogle Scholar
• Cohen J S, Kaplan M M. The SGOT/SGPT ratio– an indicator of alcoholic liver disease. Am J Dig Dis 1979; 24: 835–838
   Google Scholar
• Correia J P, Alves P S, Camilo E A. SGOT-SGPT ratios. Dig Dis Sci 1981; 26: 284
   PubMedGoogle Scholar
• Ning M, Baker H, Leevy C M. Reduction of glutamic pyruvic transaminase in pyridoxine deficiency in liver disease. Proc Soc Exp Biol Med 1966; 121: 27–30
   PubMedGoogle Scholar
• Schmidt E, Schmidt F W. Methods and value of determination of glutamic acid dehydrogenase activity in the serum. A contribution to the importance of examination of enzyme relations in the serum. Klin Wochenschr 1962; 40: 962–969
   PubMedGoogle Scholar
• Guder W G, Habicht A, Kleissl J, Schmidt U, Wieland O H. The diagnostic significance of liver cell inhomogeneity: serum enzymes in patients with central necrosis and the distribution of glu-tamate dehydrogenase in normal liver. Z Klin Chem Klin Biochem 1975; 13: 311–318
   PubMedGoogle Scholar
• van Waes L, Lieber C S. Glutamate dehydrogenase: a reliable marker of liver cell necrosis in the alcoholic. Br Med J 1977; 2: 1508–1510
   PubMedGoogle Scholar
• Jenkins W J, Peters T J. Mitochondrial enzyme activities in liver biopsies from patients with alcoholic liver disease. Gut 1978; 19: 341–344
   PubMedGoogle Scholar
• Jenkins W J, Rosalki S B, Foo Y, Scheuer P J, Nemesanszky E, Sherlock S. Serum glutamate dehydrogenase is not a reliable marker of liver cell necrosis in alcoholics. J Clin Pathol 1982; 35: 207–210
   PubMedGoogle Scholar
• Worner T M, Lieber C S. Plasma glutamate dehydrogenase: clinical application in patients with alcoholic liver disease. Alcoholism 1980; 4: 431–434
   Google Scholar
• Mills P R, Spooner R J, Russell R I, Boyle B, Mac-Sween R NM. Serum glutamate dehydrogenase as a marker of hepatocyte necrosis in alcoholic liver disease. Br Med J 1981; 23: 754–755
   Google Scholar
• Castelli W P, Doyle J T, Gordon T, et al. Alcohol and blood lipids. Lancet 1977; 2: 153–155
   PubMed Web of Science ®Google Scholar
• Sanchez-Graig M, Annis H M. Gamma-glutamyl-transpeptidase and high-density lipoprotein cholesterol in male problem drinkers: advantages of a composite index for predicting alcohol consumption. Alcohol Clin Exp Res 1981; 5: 540–544
   PubMedGoogle Scholar
• Danielsson B, Ekman R, Fex G, et al. Changes in plasma high density proteins in chronic male alcoholics during and after abuse. Scand J Clin Lab Invest 1978; 38: 113–119
   PubMed Web of Science ®Google Scholar
• Barboriak J J, Jacobson G R, Cushman P, et al. Chronic alcohol abuse and high density lipoprotein cholesterol. Alcohol Clin Exp Res 1980; 4: 346–349
   PubMedGoogle Scholar
• Hartung G H, Foreyt J P, Mitchell R E, Mitchell J GM, Reeves R S, Gotto A M. Effect of alcohol intake on high-density cholesterol levels in runners and in inactive men. JAMA 1983; 249: 747–750
   PubMed Web of Science ®Google Scholar
• Devenyi P, Robinson G M, Kapur B M, Roncari D AK. High density lipoprotein cholesterol in male alcoholics with and without severe liver disease. Am J Med 1981; 71: 589–594
   PubMed Web of Science ®Google Scholar
• Belfrage P, Berg B, Hägerstrand I, Nilsson-Ehle P, Tornqvist H, Wiebe T. Alterations of lipid metabolism in healthy volunteers during long-term ethanol intake. Eur J Clin Invest 1977; 7: 127–131
   PubMed Web of Science ®Google Scholar
• Taskinen M-R, Välimäki M, Nikkilä E A, Kuusi T, Ehnholm C, Ylikahri R. High density lipoprotein subtractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal. Metabolism 1982; 31: 1168–1173
   PubMed Web of Science ®Google Scholar
• Puchois P, Fontan M, Gentilini J-L, Gelez P, Fru-Chart J-C. Serum apolipoprotein A-II, a biochemical indicator of alcohol abuse. Clin Chim Acta 1984; 185: 185–189
   Google Scholar
• Jacobsson A, Norden A, Qvist J, Wadstein J. Serum ferritin–a new marker for alcoholism?. Acta Soc Med Suec 1978; 87: 3314–3316
   Google Scholar
• Kristenson H, Fex G, Trell E. Serum ferritin, gamma-glutamyltranspeptidase and alcohol consumption in healthy middle-aged men. Drug Alcohol Depend 1981; 8: 43–50
   PubMedGoogle Scholar
• Baxter S, Fink R, Leader A R, Rosalki S B. Laboratory tests for excessive alcohol consumption evaluated in general practice. Br J Alcohol Alcohol 1980; 15: 164–166
   Web of Science ®Google Scholar
• Korri U-M, Nuutinen H, Salaspuro M. Increased blood acetate: a new laboratory marker of alcoholism and heavy drinking. Alcohol Clin Exp Res 1985; 9: 468–471
   PubMed Web of Science ®Google Scholar
• Chalmers D M, Rinsler M G, MacDermott S, Spi-Cer C C, Levi A J. Biochemical and haematological indicators of excessive alcohol consumption. Gut 1981; 22: 992–996
   PubMed Web of Science ®Google Scholar
• Lai C L, Ng R P, Lok A SF. The diagnostic value of the ratio of serum gamma glutamyl transpeptidase to alkaline phosphatase in alcoholic liver disease. Scand J Gastroenterol 1982; 17: 41–47
   PubMed Web of Science ®Google Scholar
• Stibler H, Borg S, Allgulander C. Clinical significance of abnormal heterogeneity of transferrin in relation to alcohol consumption. Acta Med Scand 1979; 206: 275–281
   PubMedGoogle Scholar
• Stibler H, Borg S, Allgulander C. Abnormal microheterogeneity of transferrin–a new marker of alcoholism. Subst Alcohol Actions Misuse 1980; 1: 247–252
   PubMedGoogle Scholar
• Stibler H, Borg S. Carbohydrate composition of serum transferrin in alcoholic patients. Alcohol Clin Exp Res 1986; 10: 61–64
   PubMed Web of Science ®Google Scholar
• Stibler H, Borg S, Joustra M. Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption. Alcohol Clin Exp Res 1986; 10: 535–544
   PubMed Web of Science ®Google Scholar
• Stibler H, Hultcrantz R. Carbohydrate deficient transferrin (CDT) in serum in patients with liver diseases. Alcohol Clin Exp Res 1987; 11: 468–473
   PubMed Web of Science ®Google Scholar
• Gjerde H, Johnsen J, Björneboe G-E, Mörland J. A comparison of serum carbohydrate deficient transferrin with other biological markers of excessive drinking. Scand J Clin Lab Invest 1988; 48: 1–6
   PubMed Web of Science ®Google Scholar
• Behrens U, Worner T M, Lieber C S. Changes in carbohydrate-deficient transferrin levels after alcohol withdrawal. Alcohol Clin Exp Res 1988; 12: 539–544
   PubMed Web of Science ®Google Scholar
• Storey E L, Anderson G J, Mack U, Powell L W, Halliday J W. Desialylated transferrin as a serological marker of chronic excessive alcohol ingestion. Lancet 1987; 1: 1292–1293
   PubMedGoogle Scholar
• Stibler H, Borg S, Beckman G. Transferrin pheno-type and level of carbohydrate-deficient transferrin in healthy individuals. Alcohol Clin Exp Res 1988; 12(45)M53
   Google Scholar
• Panteghini M, Falsetti F, Chiari E, Malchiodi A. Determination of aspartate aminotransferase isoenzymes in hepatic diseases–preliminary findings. Clin Chim Acta 1983; 128: 133–140
   PubMedGoogle Scholar
• Nalpas B, Vassault A, LeGuillou A, et al. Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatology 1984; 5: 893–896
   Google Scholar
• Nalpas P, Vassault A, Charpin S, Lacour B, Berthelot P. Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit. Hepatology 1986; 4: 608–614
   Google Scholar
• Alveyn C G, Beresford J, Bull F G, Wright R. Mitochondrial asparate aminotransferase (mAST) as a marker of alcohol misuse in patients with liver disease and controls. Gut 1987; 28: A1349
   Google Scholar
• Kamimoto Y, Horiuchi S, Tanase S, Morino Y. Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatology 1985; 5: 367–375
   PubMed Web of Science ®Google Scholar
• Lundquist F, Tygstrup N, Winkler K, Mel-Lemgaard K, Munck-Petersen S. Ethanol metabolism and production of free acetate in the human liver. J Clin Invest 1962; 5(suppl 41)955–961
   Google Scholar
• Nuutinen H, Lindros K, Hekali P, Salaspuro M. Elevated blood acetate as indicator of fast ethanol elimination in chronic alcoholics. Alcohol 1985; 2: 623–626
   PubMedGoogle Scholar
• Schlesinger P H, Doebber T W, Mandell B F, et al. Plasma clearance of glycoproteins with terminal mannose and n-acetylglucosamine by liver non-parenchymal cells. Biochem J 1978; 176: 103–109
   PubMed Web of Science ®Google Scholar
• Hultberg B, Isaksson A, Tiderström G. Beta-hexo-saminidase, leucine aminopeptidase, cystidyl-aminopeptidase, hepatic enzymes and bilirubin in serum of chronic alcoholics with acute ethanol intoxication. Clin Chim Acta 1980; 105: 317–323
   PubMedGoogle Scholar
• Isaksson A, Blanche C, Hultberg B, Joelsson B. Influence of ethanol on the human serum level of beta-hexosaminidase. Enzyme 1985; 33: 162–166
   PubMedGoogle Scholar
• Kärkkäinen P, Poikolainen K, Salaspuro M. Serum betahexosaminidase as a marker of heavy drinking. Alcohol Clin Exp Res 1988; 23: A51
   Google Scholar
• Hubbard S C, Ivatt R J. Synthesis and processing of asparagine-linked oligosaccharides. Ann Rev Biochem 1981; 50: 555–583
   PubMed Web of Science ®Google Scholar
• Rip J W, Rupar C A, Ravi K, Carroll K K. Distribution, metabolism and function of dolichol and polyprenols. Prog Lipid Res 1985; 24: 269–309
   PubMedGoogle Scholar
• Chojnacki T, Dallner G. The biological role of dolichol. Biochem J 1988; 251: 1–9
   PubMedGoogle Scholar
• Valtersson C, Duyn G, van Verkleij A J, Chojnacki T, de Kruijff B, Dallner G. The influence of dolichol, dolichol esters and dolichyl phosphate on phospholipid polymorphism and fluidity in model membranes. J Biol Chem 1985; 260: 2742–2751
   PubMedGoogle Scholar
• Monti J A, Christian S T, Schutzbach J S. Effects of dolichol on membrane permeability. BBA 1987; 905: 133–142
   PubMedGoogle Scholar
• Wolfe L S, Ying Ng, King N MK, Palo J, Haltia M. Raised levels of cerebral cortex dolichols in Alzheimer's disease. Lancet 1982; 2: 99
   PubMedGoogle Scholar
• Wolfe L F, Ying Ng, Kin N MK, Palo J, Haltia M. Dolichols in brain and urinary sediment in neuronal ceroid-lipofuscinosis. Neurology 1983; 33: 103–106
   PubMedGoogle Scholar
• Pullarkat R K, Raguthu S R. Elevated urinary dolichol levels in chronic alcoholics. Alcohol Clin Exp Res 1985; 9: 28–30
   PubMedGoogle Scholar
• Roine R P, Turpeinen U, Ylikahri R, Salaspuro M. Urinary dolichol–a new marker of alcoholism. Alcohol Clin Exp Res 1987; 11: 525–527
   PubMedGoogle Scholar
• Salaspuro M P, Korri U-M, Nuutinen H, Roine R. Blood acetate and urinary dolichols–new markers of heavy drinking and alcoholism. Prog Clin Biol Res 1987; 241: 231–240, Goedde HW, Agarwall DP. Genetics and alcoholism
   PubMedGoogle Scholar
• Roine R P, Ylikahri R, Koskinen P, Suokas A, Hämälainen J, Salaspuro M. Effect of heavy weekend drinking on urinary dolichol levels. Alcohol 1987; 4: 509–511
   PubMedGoogle Scholar
• Roine R, Humaloja K, Hämäläinen J, Nykanen I, Ylikahri R, Salaspuro M. Significant increases in urinary dolichol levels in bacterial infections, malignancies and pregnancy but not in other clinical conditions. Ann Med 1989; 21: 13–16
   PubMed Web of Science ®Google Scholar
• Roine R P, Nykänen I, Ylikahri R, Heikkilä J, Suokas A, Salaspuro M. Effect of alcohol on blood dolichols. Alcohol Clin Exp Res 1989; 13: 347
   Google Scholar
• Salaspuro M, Kärkkäinen P, Heinonen T, et al. Evidence for lysosomal origin of increased urinary dolichols. Alcohol Clin Exp Res 1989, (in press)
   Google Scholar
• Salaspuro M, Lindroos K. Metabolism and toxicity of acetaldehyde. Alcohol related diseases in gastroenterology, H K Seitz, B Kommerell. Springer-Verlag, Berlin 1985; 106–123
   Google Scholar
• Israel Y, Hurwitz E, Niemela O, Ruth A. Monoclonal and polyclonal antibodies against acet-aldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci USA 1986; 83: 7293–7297
   Google Scholar
• Hoerner M, Behrens U J, Worner T M, et al. The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. Hepatology 1988; 3: 569–574
   Google Scholar
• Niemela O, Klajner F, Orrego H, Vidins E, Blendis L, Israel Y. Antibodies against acet-aldehyde-modified protein epitopes in human alcoholics. Hepatology 1987; 7: 1210–1214
   PubMed Web of Science ®Google Scholar
• Eriksen S P, Kulkarni A B. Methanol in normal human breath. Science 1963; 141: 639–640
   PubMedGoogle Scholar
• Gilg T, von Meyer L, Liebhardt E. Zur Bildung und Akkumulation von endogenem Methanol unter Athanolbelastung. Blutalkohol 1987; 24: 321–332
   PubMedGoogle Scholar
• Bonte W, Kuhnholz B, Ditt J. Blood methanol levels and alcoholism. Punishment and/or treatment for driving while under the influence of alcohol and other drugs, M Valverius. International Committee on Alcohol, Drugs and Traffic Safety, ICADDS, Stockholm 1985; 255–259
   Google Scholar
• Roine R P, Eriksson C JP, Ylikahri R, Penttila A, Salaspuro M. Methanol as a marker of alcohol abuse. Alcohol Clin Exp Res 1989; 13: 172–175
   PubMedGoogle Scholar
• Hahn E G, Schuppan D. Pathogenic mechanisms: fibrosis, fibrogenesis and fibrolysis. Cirrhosis of the liver: methods and fields of research, N Tygstrup, F Orlandi. Elsevier, Amsterdam 1987; 63–82
   Google Scholar
• Risteli L, Risteli J. Radioimmunoassays for monitoring connective tissue metabolism. Rheumatology 1986; 10: 216–245
   Google Scholar
• Rohde H, Vargas L, Hahn E G, Kalbfleisch H, Bruguera M, Timpl R. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 1979; 9: 451–459
   PubMed Web of Science ®Google Scholar
• Scuppan D, Dumont J M, Kim J K, Hennings G, Hahn E G. Serum concentration of the amino-terminal procollagen type III peptide in the rat reflects early formation of connective tissue in experimental liver cirrhosis. J Hepatol 1986; 3: 27–37
   PubMedGoogle Scholar
• Niemelä O, Risteli L, Sotaniemi E A, Risteli J. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease. Gastroenterology 1983; 85: 254–259
   PubMed Web of Science ®Google Scholar
• Nakano H, Kawasaki T, Miyamura M, Fukuda Y, Imura H. Serum levels of N-terminal type HI procollagen peptide in normal subjects and comparison to hepatic fibrosis. Acta Hepatol Jpn 1983; 24: 1230–1234
   Google Scholar
• Savolainen E R, Goldberg B, Leo M A, Velez M, Lieber C S. Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease. Alcoholism Clin Exp Res 1984; 8: 384–389
   PubMed Web of Science ®Google Scholar
• Colombo M, Annoni G, Donato M F, et al. Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: its relationship to hepatic fibrosis, activity of the disease and iron overload. Hepatology 1985; 4: 47S479
   Google Scholar
• Niemelä O, Riste U L, Sotaniemi E A, Risteli J. Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest 1985; 15: 132–137
   PubMed Web of Science ®Google Scholar
• Sat S, Nouchi T, Worner T M, Lieber C S. Liver fibrosis in alcoholics. Detection by fab radioimmunoassay of serum procollagen III peptides. JAMA 1985; 256: 1471–1473
   Google Scholar
• Nouchi T, Worner T M, Sato S, Lieber C S. Serum procollagen type III N-terminal peptides and lami-nin PI peptide in alcoholic liver disease. Alcoholism Clin Exp Res 1987; 11: 287–291
   PubMed Web of Science ®Google Scholar